Ropes & Gray Advised Audax Private Equity in Agreement to Sell StatLab Medical Products

Ropes & Gray represented Audax Private Equity in an agreement with Linden Capital Partners to sell StatLab Medical Products to Leica Biosystems, an operating company of Danaher Corporation (NYSE: DHR). The transaction was announced on July 14.

Founded in 1976 and headquartered in McKinney, Texas, StatLab is a leading manufacturer of pre-analytical products spanning the full anatomic pathology workflow, delivering high-quality products and expert service to laboratories and OEM customers across the United States and Europe.

Headquartered in Boston, with offices in San Francisco, New York, London and Hong Kong, Audax Private Equity is a leading private equity platform focused on investing across the North American middle market. The firm’s objective is to accelerate value creation through its Buy & Build strategy and the Audax Value Agenda™, a holistic framework that seeks to create, enable, and protect value across every stage of the investment lifecycle. As of January 2026, Audax Private Equity had approximately $19.5 billion of assets under management and, since inception in 1999, has invested in more than 180 platforms and more than 1,500 add-on acquisitions.

The team included private equity partners Chau Le and Reed Harasimowicz, private equity counsel Peter Wang, antitrust partners Samer Musallam and Ruchit Patel, tax partner Scott Pinarchick, and tax counsel Tom Spera.